Epic Medical Research operates across 14 state-of-the-art locations in four states, offering full-spectrum clinical trial capabilities across a broad range of therapeutic areas—including metabolic disorders, fatty liver disease (NASH), sleep apnea, obesity, endocrine disorders, pulmonary and gastrointestinal diseases, neurological and psychiatric conditions, pediatrics, rheumatology, dermatology, podiatry, and infectious diseases. With two advanced Phase I units, an on-site sleep lab, and a dedicated laboratory for end-to-end PBMC processing, Epic provides the infrastructure and scientific expertise required to support trials from early development through late-phase execution.